Care New England to continuously monitor patients across a variety of conditions with Biofourmis’ proven technology, offering predictive insight to Integra clinicians Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers…
Chief Technology Officer and Senior Vice President of Product will help scale company to meet market demand for an enterprise solution to deliver healthcare at home Current Health, an enterprise care-at-home platform, announced that it…
Chief Strategy Officer, Chief Customer Officer, and VP of Marketing hired to support adoption and scale of company’s care-at-home platform Current Health, the leading enterprise care-at-home platform, announced three additions to its executive team: Chris…
Survey finds 69% of health systems experienced high levels of patient and provider satisfaction and saw reduced hospital admissions with remote care in the last 12 months Current Health, the leading enterprise care at home…
With $3M Grant, UArizona-Led Center to Advance At-Home Health Care Technology The last two decades have seen an uptick in people choosing to monitor their health using wearable technologies such as Fitbits and Apple Watches….
Sheeza Khawar Hussain to Accelerate Market Growth for Biofourmis’ Care-at-Home Technology Solutions, including Hospital at Home Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, has named global healthcare marketing and sales leader…
Coalition advocates for policy changes to support the shift to home-based care Current Health, the leading enterprise remote care management platform, today announced it has joined Moving Health Home (MHH), a coalition of healthcare companies committed to…
Combined Entity Provides a Comprehensive, Whole-Person Approach to Provide Care to the Most Vulnerable and Underserved Individuals with Serious Illness Vynca, a national leader in advance care planning, today announced that it has acquired California-based…
$15m Raise for SFO-based DCT startup Curebase to shake up clinical trial model Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities,…